Establishment of a Group Structure Including Consolidated Subsidiaries and Equity-Method Affiliates
First written in FY2016-Q3. 11 of 24 entries say "Restated". Latest entry: FY2026.
6 other companies' latest entry also says "Other".
- FY2026Changes in the group-company structureAnnual report
「The Group, consisting of the Company and its affiliates, comprises the Company, Pharma Foods International Co.,Ltd., 7 subsidiaries and 1 affiliate.」
The sale of all Benato shares reduced the number of equity-method affiliates, resulting in a structure comprising 7 subsidiaries and 1 affiliate. - FY2023AdvancedAnnual report
「The group (the company and its group companies) consisted of the company (Pharma Foods Co., Ltd.), 7 subsidiaries and 2 affiliates.」
The group structure comprised 7 subsidiaries, including PF Visionary Fund and PF Capital, which had become wholly owned subsidiaries, and Onkyo and others, as well as 2 affiliates. - FY2023-Q1RestatedAnnual report
「The company acquired shares of PF Capital Co., Ltd. and made it a subsidiary on 13 May 2022 (deemed acquisition date: 30 June 2022), and acquired shares of Onkyo Co., Ltd. and applied the equity method on 25 May 2022 (deemed acquisition date: 30 June 2022). Accordingly, the results of PF Capital Co., Ltd. and Onkyo Co., Ltd. have been included from the first quarter of the fiscal year under review.」
Following the inclusion of PF Capital as a subsidiary and the application of the equity method to Onkyo, the results of both companies have been included in the scope of consolidation or equity-method accounting from the current quarter, as reconfirmed. - FY2022AdvancedAnnual report
「The group (the company and its group companies) consisted of the company (Pharma Foods Co., Ltd.), 6 subsidiaries and 2 affiliates.」
The group structure expanded to include Meiji Yakuhin and PF Capital as subsidiaries and Onkyo as an affiliate. - FY2022-Q3RestatedAnnual report
「The company acquired all shares of Meiji Yakuhin Co., Ltd. on 31 August 2021 and made it a consolidated subsidiary.」
The acquisition of all shares of Meiji Yakuhin and its inclusion as a consolidated subsidiary have been reconfirmed. - FY2022-Q2RestatedAnnual report
「There were no material changes in the businesses conducted by the group (the company and its group companies) during the six months ended .... Regarding changes among the major group companies, all shares of Meiji Yakuhin Co., Ltd. were acquired on 31 August 2021, and the company was made a consolidated subsidiary.」
The group structure with Meiji Yakuhin as a consolidated subsidiary has been reconfirmed. - FY2022-Q1AdvancedAnnual report
「Following the acquisition by the company of all issued shares of Meiji Yakuhin Co., Ltd. as of 31 August 2021, Meiji Yakuhin Co., Ltd. was newly included as a consolidated subsidiary. As a result, as of 31 October 2021, the group consisted of the company, 4 consolidated subsidiaries and 1 affiliate.」
The acquisition of all shares of Meiji Yakuhin was completed, resulting in a group structure comprising 4 consolidated subsidiaries and 1 affiliate. - FY2021AdvancedAnnual report
「The company acquired shares of Meiji Yakuhin Co., Ltd. and made it a subsidiary, with the aim of expanding its functional materials and mail-order businesses (the company's ownership interest: 100%; currently a consolidated subsidiary).」
Meiji Yakuhin became a wholly owned subsidiary as of 31 August 2021, after the filing date, expanding the group structure. - FY2021-Q2RestatedAnnual report
「There were no material changes in the businesses conducted by the group (the company and its group companies) during the six months ended .... There were also no changes among the major group companies.」
It has been reconfirmed that there have been no material changes to the group's business activities or principal affiliated companies. - FY2021-Q1AdvancedAnnual report
「Date of business combination 1 August 2020 Legal form of the business combination Absorption-type merger with Pharma Foods Communication Co., Ltd. as the surviving company and fit Call Tokai G.K. as the disappearing company Voting rights acquired 100%」
The group structure was expanded and integrated through the full acquisition of a call-center operator and an absorption-type merger with Pharma Foods Communication as the surviving company. - FY2020-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among the principal affiliated companies.」
It reconfirms that there have been no material changes to the Group's businesses or major affiliated companies. - FY2020-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliates, during the first quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates.」
The company reconfirmed that there had been no material changes in the group structure, including consolidated subsidiaries and affiliates. - FY2019-Q3RestatedAnnual report
「CAF Co., Ltd., formerly an equity-method affiliate, was excluded from the scope of equity-method accounting during the second quarter of the fiscal year under review following the sale of all shares held by the company.」
The exclusion of CAF Co., Ltd. from the scope of equity-method accounting following the sale of all its shares has been reconfirmed. - FY2019-Q2Changes in the group-company structureAnnual report
「CAF Co., Ltd., formerly an equity-method affiliate, was excluded from the scope of equity-method accounting during the second quarter of the fiscal year under review following the sale of all shares held by the company.」
CAF Co., Ltd. was excluded from the scope of equity-method accounting following the sale of all its shares. In addition, the call-center subsidiary was made a wholly owned subsidiary. - FY2019-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliates, during the first quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates.」
The company reconfirmed that there had been no material changes in the businesses or major group companies within the group structure, including consolidated subsidiaries and affiliates. - FY2018-Q3RestatedAnnual report
「There were no material changes in the businesses of the group (the company and its group companies) during the nine months ended .... There were also no changes among the major group companies.」
The company reconfirmed that there had been no material changes in the businesses or major group companies within the group structure, including consolidated subsidiaries and affiliates. - FY2018-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, there were no material changes to the business activities conducted by the Group (the Company and its affiliated companies). There were also no changes among the principal affiliated companies.」
The company reconfirmed that there had been no material changes in the businesses or major group companies within the group structure, including consolidated subsidiaries and affiliates. - FY2018-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliates, during the first quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates.」
The company confirmed that there had been no material changes in the businesses or major group companies within the group structure formed by the previous quarter. - FY2017-Q3Changes in the group-company structureAnnual report
「As all shares of Pharma Foods Korea Co.,Ltd., formerly an affiliate, were sold during the third quarter of the fiscal year under review, the company was excluded from the scope of equity-method accounting. As a result, as of 30 April 2017, the group consisted of the company, 3 consolidated subsidiaries and 2 affiliates.」
While maintaining a structure of 3 consolidated subsidiaries, including Future Lab and others, the number of affiliates fell to 2 following the sale of all shares of Pharma Foods Korea. - FY2017-Q2AdvancedAnnual report
「As a result, as of 31 January 2017, the group consisted of the company, 3 consolidated subsidiaries and 3 affiliates.」
The structure comprising 3 consolidated subsidiaries, including Future Lab and its 100%-owned subsidiary Medilabo, has been established, giving concrete form to the group structure. - FY2017-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 October 2016, the company resolved to acquire all shares of Future Lab Co., Ltd. and make it a subsidiary, entered into a share transfer agreement on the same date, and acquired all shares on 1 November 2016.」
Specific progress has been made toward adding a mail-order and cosmetics sales company as a wholly owned subsidiary to the existing group structure. - FY2016-Q3First statedAnnual report
「As Pharma Foods Communication Co., Ltd. was newly established from the first quarter of the fiscal year under review, it has been included in the scope of consolidation.」
The company began preparing consolidated financial statements from the first quarter beginning in August 2015, with 1 subsidiary and 3 affiliates included in consolidation or accounted for under the equity method.